Understanding Left Ventricular Hypertrophy and Survival Rates

Illustration of left ventricular hypertrophy physiology

Intro

Left ventricular hypertrophy (LVH) is a condition that often surfaces in discussions surrounding cardiovascular health but receives less attention than it perhaps should. This thickening of the heart's left ventricle can be a silent indicator of heart health deterioration, with roots stemming from various underlying conditions such as hypertension and valvular heart disease. By peeling back the layers of LVH, we gain insight not just into its physiological mechanisms, but also how it pertains to patient survival rates.

The relevance of understanding this condition lies in its potential implications for intervention strategies. As we navigate through this article, it becomes apparent that recognizing LVH is imperative for timely medical response and improved long-term outcomes. The journey will involve examining key findings from recent research, dissecting methodologies employed in studies, and ultimately piecing together a narrative that supports healthier futures for patients grappling with this condition.

With this groundwork laid, let’s delve into the current research landscape concerning LVH.

Prolusion to Left Ventricular Hypertrophy

Left ventricular hypertrophy (LVH) is more than just a medical term; it encompasses a significant condition that can greatly affect cardiovascular health. Recognizing the importance of LVH in the landscape of heart disease is crucial for anyone studying or working in the medical field. This condition often goes unnoticed until it has progressed to a more serious state, highlighting the need for early detection and understanding.

Definition and Mechanisms

LVH refers specifically to the thickening of the muscular walls of the heart's left ventricle. This thickening can be a response to various load stresses, such as high blood pressure or increased physical exertion. Essentially, the heart adapts to accommodate the elevated demands placed on it, but this adaptation can lead to adverse outcomes.

From a mechanistic standpoint, LVH develops through a complex interplay of biochemical and hemodynamic processes. Other than hypertension, factors such as hormonal influences and genetic predisposition also play pivotal roles. The cumulative effect is an alteration of the cardiac architecture that compromises overall heart function.

Pathophysiological Changes

The journey into understanding LVH requires a look at how it triggers structural and functional shifts within the heart. Such changes can be dissected further into:

Cardiac Muscle Remodeling

Cardiac muscle remodeling refers to the physical and functional changes that occur in the heart as a response to sustained injury or stress. In LVH, this remodeling results in hypertrophy or thickening of the myocardial tissue. A unique feature of cardiac muscle remodeling is the reorganization of muscle fibers, which can lead to increased mass but impaired contraction ability.

Consider this: when the heart is pushed harder and longer, like a car engine revving too much, it may not function in an efficient manner over time. While muscular enhancement might seem beneficial at first glance, it often leads to complications, such as decreased elasticity and impaired electrical conduction.

Advantages:
Disadvantages:

Increased myocardial mass can temporarily bolster cardiac output during physical demands.
The heart may initially cope with excessive workload better due to enhanced contractility.

As hypertrophy progresses, the heart becomes less compliant, leading to diastolic dysfunction.
The risk of heart failure and arrhythmias escalates significantly with ongoing remodeling.

Impact on Cardiac Output

The impact LVH has on cardiac output is another vital piece of the puzzle. Initially, patients may experience a boost in cardiac output. However, as the condition evolves, it can swing the other way, resulting in reduced efficiency and output.

The heart's ability to pump blood becomes compromised due to the thickened walls. Specifically, the left ventricle may become less effective at relaxing and filling with blood, ultimately decreasing the volume pumped with each contraction. Thus, while enhanced muscle thickness can temporarily improve performance, the long-term implications can be counterproductive.

Advantages:
Disadvantages:

Improved cardiac output in early stages allows for higher activity tolerance.
Some patients may feel fewer symptoms initially, misleading them about their true cardiac health.

Long-term reduced stroke volume and cardiac output can manifest as fatigue and reduced exercise capacity.
The heart struggles to meet the body’s demands during stress or exertion.

Understanding these intricate relationships of LVH is pivotal, as it lays the groundwork for discussing the survival rates of individuals diagnosed with this condition in forthcoming sections, helping us frame the ongoing dialogue about prevention and treatment.

Epidemiology of Left Ventricular Hypertrophy

The understanding of how widespread left ventricular hypertrophy (LVH) is among different populations offers critical insights into its significance as a public health concern. Epidemiology delves into the patterns and determinants of this condition, allowing for a more informed approach to patient care and stratification. Recognizing the impact of LVH can facilitate targeted screening strategies, informing how healthcare systems allocate resources and manage care for at-risk groups.

Prevalence Across Populations

Studies continuously elucidate the prevalence of LVH among various demographics, revealing that it isn’t an isolated phenomenon. Recent data indicates that approximately 20-30% of the elderly population exhibit signs of LVH. This prevalence is particularly noted among individuals suffering from longstanding hypertension. Conversely, among younger populations, particularly athletes, LVH can manifest as a physiological response to rigorous training regimens, complicating its diagnosis.

Observations suggest that the prevalence of LVH varies significantly based on factors like age, gender, and underlying health conditions. It’s vital, thus, for clinicians to recognize these disparities and tailor their approaches when managing patients, ensuring that those at higher risk receive prompt diagnosis and treatment.

Demographic Variances

Age and Gender Differences

Age and gender play pivotal roles in the manifestation and progression of LVH. As individuals age, the heart undergoes structural changes that can predispose one to LVH. In men, the likelihood of developing this condition increases considerably as they advance into their fifties. This stark contrast with women, who typically experience a later onset post-menopause, highlights how hormonal changes might influence cardiac structure in both genders.

It’s also noted that men tend to exhibit higher blood pressure levels early in life, contributing to greater incidences of LVH compared to women. The implications here are twofold; first, it lends weight to the necessity for gender-specific screening guidelines, and second, it urges the need for tailored prevention strategies.

Key Characteristic: The differential onset and prevalence of LVH between genders can influence the overall course of treatment.
Unique Feature: The biological understanding of heart function in relation to gender differentiates patient management in clinical settings, leading to optimized outcomes.

Associations with Ethnicity

The prevalence of LVH also intersects with various ethnic backgrounds. Studies reveal that African Americans are diagnosed with LVH at an alarming rate compared to their Caucasian counterparts. This disparity can often be linked to higher incidences of hypertension, diabetes, and obesity, conditions often more prevalent in this demographic.

Understanding such associations is essential for several reasons:

It emphasizes the need for culturally competent healthcare strategies that resonate with the values and beliefs of diverse communities.
Through awareness, healthcare professionals can fine-tune intervention strategies that address the unique risks associated with these groups.

Key Characteristic: Ethnic backgrounds can serve as major indicators of an individual's risk profile for developing LVH.
Unique Feature: This focus on ethnicity allows for a more granular understanding of health disparities, aiding further research and guiding public health initiatives to curb LVH incidence.

In sum, recognizing the epidemiological landscape of left ventricular hypertrophy is not merely academic; it paves the way for informed public health policies and clinical practices that ultimately enhance patient outcomes. This awareness around the varying prevalence and demographic factors underscores the importance of individualized care and preventive measures aimed at curtailing the development of cardiological complications.

Causes of Left Ventricular Hypertrophy

Understanding the causes of left ventricular hypertrophy (LVH) is crucial. By identifying these factors, we can pinpoint methods for prevention and treatment. LVH isn’t merely an isolated condition; it often signals underlying issues which, if not addressed, can lead to severe health complications. Grasping the causes allows healthcare professionals to design effective intervention strategies and helps patients mitigate risks associated with this condition.

Hypertension's Role

Hypertension is a primary driver of LVH. High blood pressure forces the heart to pump harder, putting strain on the left ventricle. With time, this increased workload causes the muscle to thicken, a process known as hypertrophy. As a result, the heart becomes less efficient. Managing hypertension is vital, not only for controlling blood pressure but also for preserving heart health.

Research has shown that individuals with untreated high blood pressure are at a significantly greater risk for developing LVH and related cardiac issues. Regular monitoring and appropriate intervention can slow or possibly reverse this process, highlighting the significance of addressing hypertension early.

Genetic Predispositions

Inherited Cardiac Conditions

Inherited cardiac conditions play a significant role in the development of LVH. These are genetic disorders that influence heart structure and function. Conditions such as hypertrophic cardiomyopathy often run in families. A key characteristic of these inherited issues is their ability to present with symptoms from a young age, distinguishing them from other causes of LVH that may develop later in life.

What sets these inherited conditions apart is their direct effect on heart muscle cells. They may cause the muscle to grow abnormally without the increased workload seen in hypertensive patients. Understanding these conditions allows for early intervention, helping those at risk manage or even prevent the onset of LVH.

Risk Factors from Family History

Family history is another compelling indicator of LVH risk. A person with a parent or sibling who has had LVH or related cardiovascular problems may have an inherent predisposition. The key idea here revolves around hereditary factors that can significantly elevate one's risk.

The genetic component often manifests in lifestyle habits or physiological traits common within families. Moreover, knowing family history can be beneficial in formulating preventive strategies. It encourages proactive screening, especially in younger family members, who might otherwise overlook their risks.

Other Contributing Factors

Obesity and Metabolic Syndrome

Obesity and metabolic syndrome are major contributors to LVH. Extra body weight puts an increased demand on the heart. Obesity is often accompanied by other health issues such as diabetes, which can compound this stress.

The distinctive characteristic of metabolic syndrome is a cluster of conditions—high blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels—that together increase the risk of heart disease. Addressing obesity through lifestyle changes can significantly reduce the risk of LVH, making it a vital component of any discussion on heart health.

Endurance Training Effects

Interestingly, not all hypertrophy is adverse. Endurance training, typical in athletes, can lead to a condition known as athlete's heart, where the heart muscle adapts positively to the demands of intense exercise. This physiological change differs from pathological LVH; it stems from training rather than disease.

Here’s the nuance: while athlete's heart is usually considered benign, it’s essential to monitor such changes closely. Distinguishing between physiological and pathological hypertrophy helps avoid misdiagnosis and unnecessary treatment, underscoring the need for tailored evaluations in athletes.

Clinical Implications of Left Ventricular Hypertrophy

Left Ventricular Hypertrophy (LVH) is not merely a clinical term; it’s a significant health issue that carries serious implications for patients. Understanding the clinical ramifications of LVH is crucial for medical practitioners, educators, and researchers, as it informs treatment strategies and patient management efforts. LVH influences patient outcomes beyond the diagnosis; it is a predictor of future cardiovascular incidents, heart failure, and mortality. Therefore, recognizing its implications is essential for optimizing patient care and survival.

Symptoms and Diagnosis

Common Symptoms

The symptoms of left ventricular hypertrophy can be somewhat elusive. Many patients may not exhibit overt signs until the condition has progressed significantly. In such cases, doctors often note a few key signs: fatigue, shortness of breath, and palpitations. These symptoms can be easily dismissed or attributed to other conditions, which can delay diagnosis.

The key characteristic of common symptoms is their insidious nature. Patients might overlook fatigue as a sign of a busy lifestyle, which can lead to a dire situation where effective treatment is postponed. A unique feature of these symptoms is their variability; some patients might experience severe symptoms despite having mild LVH, whereas others might show moderate symptoms with advanced hypertrophy.

These nuances highlight the need for regular monitoring of at-risk individuals. Recognizing common symptoms allows for timely intervention, which can dramatically improve prognosis and quality of life.

Diagnostic Tools and Techniques

Diagnosing LVH effectively requires a thorough approach, involving various tools and techniques. The most prevalent methods include ECG, echocardiography, and MRI. Each of these tools provides valuable insights into the heart's structure and function, allowing practitioners to make informed decisions regarding treatment options.

The key characteristic of these diagnostic tools is their capacity to visualize cardiac abnormalities non-invasively. For instance, echocardiography stands out because it not only detects hypertrophy but also assesses chamber sizes and functional impairments. The unique feature of these techniques is their ability to contribute to a comprehensive cardiac assessment, which is crucial for planning effective management strategies. However, each method has its disadvantages; for example, an ECG may not detect mild LVH, calling for further imaging to confirm diagnosis.

Cardiac Risks Associated with LVH

Heart Failure Risk

Diagram illustrating interventions for improving heart health

One of the most pressing concerns associated with LVH is the elevated risk of heart failure. As the heart muscle thickens, it becomes less efficient at pumping blood, leading to potential heart failure. The characteristic feature of this risk is that it often arises silently, and many patients remain unaware until they experience acute symptoms.

The implications for clinical practice are significant. Identifying patients with LVH is therefore paramount as addressing this risk early may delay or even prevent the onset of heart failure. The unique aspect to consider here is that treatment, often through lifestyle changes or medication, can significantly alter outcomes.

Still, a potential downside is the complexity of managing those identified at high risk from the outset. Clinicians must weigh the immediate risks of intervention against the long-term benefits to ensure optimal patient care, which can often complicate clinical decision-making.

Arrhythmias and Sudden Cardiac Death

LVH is closely linked to an increased risk of arrhythmias, which can be fatal. Arrhythmias occur when the electrical impulses in the heart don't fire correctly, leading to irregular heartbeats. Sudden cardiac death, though a less frequent outcome, poses a critical concern. The connection between LVH and arrhythmias stems from the structural changes in the heart muscle that disrupt normal electrical conduction.

The primary characteristic here is the unpredictable nature of arrhythmias. They can manifest during physical activity or rest, making it hard to determine which patients are at greater risk. With proper assessment techniques, however, healthcare providers can identify patients most likely to experience serious arrhythmias, emphasizing the importance of continuous monitoring and assessment.

A unique aspect of this risk is its interplay with other factors. For instance, the presence of hypertension or genetic predispositions can exacerbate the likelihood of arrhythmias. The implications are significant; identifying these high-risk individuals is essential to implementing preventative strategies and potentially life-saving interventions.

"The complexities surrounding LVH necessitate a comprehensive understanding of its clinical implications for effective management."

Understanding these clinical implications of LVH enables healthcare providers to make informed decisions regarding patient management, ultimately improving survival rates and quality of life.

Patient Survival Rates in Left Ventricular Hypertrophy

Understanding the survival rates in left ventricular hypertrophy (LVH) is essential for appreciating the broader implications of this condition on cardiac health. Survival outcomes can shed light on the effectiveness of various interventions and guide clinical decision-making. Several factors play into how LVH influences overall survival rates, including age, underlying health conditions, and response to treatments.

Factors Influencing Survival

Age and Comorbidities

When we talk about age and comorbidities, it's critical to recognize their weight in determining the survival chances of patients with LVH. As individuals age, the likelihood of encountering other health issues such as diabetes, heart disease, or respiratory problems increases. These comorbidities can exacerbate the effects of LVH, leading to poorer health outcomes. For instance, an older patient with LVH is more likely to have hypertension or renal problems, which complicate the treatment landscape.

Key characteristic: The interaction between LVH and other conditions can create a complex health picture. This characteristic is particularly significant in middle-aged and elderly populations where comorbidities may mask the symptoms of LVH or how it presents.

Unique feature: Each additional health factor can introduce variability into treatment effectiveness. For instance, older patients may not respond as robustly to certain medications as younger patients, impacting overall survival rates adversely. It's also a double-edged sword; while age can lead to diminished physiological resilience, it can also encourage proactive management and lifestyle changes.

Response to Treatment

The response to treatment plays a pivotal role in patient outcomes related to LVH. Various therapies aim to manage the condition and mitigate risks associated with hypertrophy. Patients who respond well to treatment tend to show marked improvements in their survival rates. That can include medication adherence, regular follow-up, and lifestyle changes that can help turn the tide.

Key characteristic: The effectiveness of prescribed treatments can vary significantly among patients, influenced by genetic factors and adherence to medical advice. Overall, those who actively engage in their health management typically enjoy much better survival prospects than those who do not.

Unique feature: Monitoring treatment response can highlight areas for intervention. For example, if a patient's condition worsens despite medication, clinicians may reassess their entire treatment plan, potentially pivoting to more aggressive strategies aimed at improving heart function.

Recent Statistics and Research Findings

Recent studies provided valuable insights into how LVH impacts survival outcomes across populations. National databases have reported a concerning trend; survival rates for individuals with LVH show a notable decline, particularly in those who delay intervention or do not heed medical guidance. Statistically, early detection and proactive management can improve the outlook by up to 30%, showing how timely action can be a game changer.

Comparative Studies on Survival Rates

LVH in Hypertensive Patients

Hypertensive patients present a unique case when considering survival rates associated with LVH. Chronic high blood pressure often forms a causative pathway for the development of LVH. In these patients, the structural changes in the heart can significantly derail survival rates. The overwhelming evidence suggests that patients with LVH due to hypertension experience higher risks of heart failure and arrhythmias than those without such complications.

Key characteristic: Understanding the relationship between hypertension and LVH is crucial for developing targeted interventions that improve patient survival.

Unique feature: Patients with both conditions often require tighter control of their blood pressure, highlighting the interplay between effective hypertension management and survival.

LVH in Athletes

On the other end of the spectrum, athletes might develop LVH due to rigorous training regimens. This phenomenon, often termed "athlete's heart," can complicate comparisons of survival rates since LVH in this population may not always correlate with the same risks tied to sedentary individuals with similar findings on imaging techniques. Yet, studies suggest that while athletes experience some degree of heart remodeling, it does not equate to the same long-term risks associated with pathological LVH.

Key characteristic: The physiological adaptation of the heart can lead to slight increases in mass without an accompanying increase in associated morbidity or mortality.

Unique feature: This distinction highlights the need for careful interpretation of LVH in active individuals, reminding us that lifestyle factors significantly influence survival outcomes.

Preventative Measures and Management of Left Ventricular Hypertrophy

Understanding how to prevent and manage left ventricular hypertrophy (LVH) is crucial because it’s a condition that doesn’t just affect one’s heart but can have broader implications on overall health. Focusing on prevention can lead to better quality of life and ultimately improve survival rates. This section explores essential lifestyle modifications and the role of medications and interventions in managing LVH.

Lifestyle Modifications

Nutrition and Weight Management

Graph showing survival rates related to LVH

When it comes to the management of LVH, nutrition and weight management play a pivotal role. A heart-healthy diet can help lower blood pressure and reduce the workload on the heart. This kind of diet often emphasizes fruits, vegetables, whole grains, and lean proteins while limiting saturated fats and salt.

Key characteristics of this dietary approach include:

Rich in omega-3 fatty acids which can help control inflammation.
High fiber content that promotes cardiovascular health and aids in weight management.

A popular choice among individuals managing LVH is the Mediterranean diet, known for its heart-protective benefits. It focuses on healthy fats like olive oil and fish, which are beneficial for overall heart health. One unique feature of this diet is its flexibility, making it easier for people to adhere to it long term. This can be an advantage in consistently managing weight and reducing strain on the heart.

However, there are disadvantages, such as the potential for increased caloric intake if portion sizes are not monitored properly. Without careful management, even healthy foods can contribute to weight gain, which is counterproductive to addressing LVH.

Exercise Regimens

Exercise is another cornerstone of LVH management. Engaging in regular physical activity helps strengthen the heart muscle, making it more efficient. Whether one chooses aerobic activities like walking or more structured cardiovascular workouts can significantly influence heart health

The key characteristic of exercise regimes aimed at managing LVH is their ability to improve both heart function and overall fitness levels. For instance, moderate-intensity aerobic exercise for about 150 minutes a week is often recommended. This can be something as simple as brisk walking or cycling.

What makes exercise particularly appealing is its dual benefits; it helps manage weight while also lowering blood pressure. However, it’s crucial to consider individual capabilities when starting a new exercise regimen. Overdoing it can lead to stress on the heart, especially in those with existing conditions.

Medications and Interventions

When lifestyle modifications alone do not suffice, medications often become necessary to manage LVH. They can help reduce the heart's workload and improve outcomes.

First-Line Pharmacological Treatments

First-line treatments generally include ACE inhibitors, beta-blockers, and diuretics. These medications are notable for their ability to reduce hypertension, a leading cause of LVH.

The key characteristic of these treatments is their direct action on heart function. For instance, beta-blockers lower heart rate while ACE inhibitors help relax blood vessels. This dual action can significantly mitigate the strain on the heart.

Many physicians advocate for these medications due to their proven effectiveness in clinical trials. Still, there are potential side effects such as fatigue or dizziness, which patients need to be aware of. Managing the dosage is essential to maximizing benefits while minimizing adverse effects.

Long-term Management Strategies

Long-term management strategies are about sustaining health improvements over time. This can include a combination of ongoing medication and regular follow-ups with healthcare providers. These strategies are often personalized based on individual responses to treatment and lifestyle modifications.

The hallmark of long-term strategies lies in their holistic approach. For instance, regular monitoring of blood pressure, heart function, and lifestyle habits is essential. This proactive approach can lead to better management of LVH and help avoid complications later down the road.

Future Directions in Research

In the context of left ventricular hypertrophy (LVH), ongoing research is crucial. The rapidly evolving understanding of LVH and its implications can lead to significant advancements in treatment and prevention strategies. This section delves into the emerging treatment approaches and the genetic aspects tied to LVH, showcasing their relevance in today’s clinical landscape.

Innovative Treatment Approaches

As the medical community gains insights into LVH, innovative treatment options are coming to light. These approaches often combine traditional therapies with cutting-edge technologies.

Targeted Pharmacotherapy: Medications that specifically target the molecular pathways involved in cardiac remodeling may provide a more effective response. Recent studies suggest that drugs like angiotensin receptor blockers can mitigate LVH progression.
Gene Therapy: Advances in gene editing could pave the way for therapies that correct genetic predispositions contributing to LVH, thereby offering potential solutions for at-risk populations.
Device-Based Therapies: Implantable devices, such as cardiac resynchronization therapy, can improve heart function. Such devices are increasingly being evaluated for their effectiveness in managing hypertrophy-related complications.
Personalized Medicine: The rise of genetic profiling can lead to tailored treatment plans that accommodate individual risk factors and responses, ultimately aiming to enhance treatment outcomes.

The integration of these innovative techniques signifies a shift towards a more personalized approach in managing LVH.

Understanding Genetic Contributions to LVH

Genetics play a pivotal role in the development of LVH, making it essential to understand hereditary factors influencing this condition. Research has illuminated several genetic pathways that could enhance the understanding of LVH:

Familial Patterns: Certain inherited conditions, such as hypertrophic cardiomyopathy, showcase a clear genetic link. Recognizing these patterns can help clinicians identify at-risk individuals before significant cardiac changes occur.
Biomarkers: Identifying specific genetic markers associated with LVH can provide insights into individual risk levels and the effectiveness of potential therapies.
Genomic Research: Studies aimed at uncovering the genetic underpinnings of LVH can reveal novel targets for drug development.
Environmental Interactions: It’s equally important to consider how genetics interact with lifestyle factors, such as diet and exercise, to influence LVH development.

By expanding research efforts in this area, the understanding of LVH can evolve, leading to stronger preventive strategies and more effective treatments.

"Understanding the genetic contribution to LVH is pivotal for future breakthroughs in clinical practice and research. Identifying specific genetic pathways holds the key to unlocking personalized treatment plans."

The exploration of innovative treatment approaches and genetic contributions emphasizes the dynamic field of LVH research. As scientists and healthcare professionals join hands in these efforts, the potential to improve patient outcomes becomes increasingly tangible.

Culmination

In this article, we have delved deeply into the nuances of left ventricular hypertrophy (LVH), particularly focusing on its survival rates and the consequential implications for patients. Understanding this critical condition requires comprehending its multifaceted layers—from the mechanisms that trigger hypertrophy to the various outcomes shaping the lives of those affected.

Recapitulation of Key Insights

As we reflect on the various insights presented, it is paramount to consider the following key points that have emerged:

Definition and Mechanisms: LVH occurs as a response to increased cardiac workload, often due to hypertension or other conditions impacting cardiac health. The structural changes in heart muscle can significantly alter its function.
Epidemiology: The diverse prevalence rates across different populations illuminate the need for targeted screenings and interventions based on demographics, particularly age and ethnicity.
Risk Factors: Numerous factors contribute to the development of LVH, including genetic predispositions, lifestyle choices, and medical conditions like obesity or diabetes.
Survival Rates: Survival rates are influenced by several variables such as comorbidities, treatment responsiveness, and early diagnosis. Recent data suggests that when managed appropriately, patients can have markedly improved outcomes.

Ultimately, a clear understanding of these components emphasizes the importance of early recognition and proactive management of LVH.

Implications for Future Research and Practice

Looking ahead, there are several critical areas where further research could yield impactful results in managing LVH:

Innovative Treatment Approaches: Research exploring new therapeutic options or lifestyle interventions may provide patients with better management strategies, thus improving their quality of life.
Genetic Research: Understanding the genetic underpinnings associated with LVH can lead to more personalized treatment approaches. Assessments of family history and genetic testing can allow for earlier intervention in at-risk individuals.
Longitudinal Studies: More extensive and robust studies that track individuals over time can identify patterns, and potentially prevent LVH from developing or worsening before it becomes critical.

Have More Awesome Stuff:

Anatomy of the liver highlighting cirrhosis effects